0000945621-19-000016.txt : 20190115 0000945621-19-000016.hdr.sgml : 20190115 20190115095644 ACCESSION NUMBER: 0000945621-19-000016 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190115 DATE AS OF CHANGE: 20190115 EFFECTIVENESS DATE: 20190115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kleo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001700389 IRS NUMBER: 475508437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-330541 FILM NUMBER: 19526360 BUSINESS ADDRESS: STREET 1: 25 SCIENCE PARK, SUITE 2D STREET 2: 150 MUNSON ST. CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-691-6332 MAIL ADDRESS: STREET 1: 25 SCIENCE PARK, SUITE 2D STREET 2: 150 MUNSON ST. CITY: NEW HAVEN STATE: CT ZIP: 06511 D 1 primary_doc.xml X0708 D LIVE 0001700389 Kleo Pharmaceuticals, Inc. 25 SCIENCE PARK, SUITE 2D 150 MUNSON ST. NEW HAVEN CT CONNECTICUT 06511 203-691-6332 DELAWARE None None Corporation true 2015 Roy Prieb 25 Science Park, Suite 2D 150 Munson St. New Haven CT CONNECTICUT 06511 Executive Officer Director Douglas Manion 25 Science Park, Suite 2D 150 Munson St. New Haven CT CONNECTICUT 06511 Executive Officer Director Declan Doogan 45 Ocean Crest Wat Unit 1032 Palm Coast FL FLORIDA 32137 Director Alexander Goor 25 Science Park, Suite 2D 150 Munson St. New Haven CT CONNECTICUT 06511 Director Charles G. Drake c/o Columbia University Medical Center 177 Fort Washington Avenue, St, 6GN-435 New York NY NEW YORK 10032 Director John W. Childs c/o J.W. Childs Associates, L.P. 500 Totten Pond Road, 6th Floor Waltham MA MASSACHUSETTS 02451 Director Pharmaceuticals Decline to Disclose 06b false 2018-11-12 false true false 0 21206378 21206378 0 false 19 0 0 0 true false Kleo Pharmaceuticals, Inc. /s/ Roy Prieb Roy Prieb Chief Operating Officer, Chief Financial Officer, Secretary 2019-01-09